Melanoma Negative for bRAF
2 clinical trials · Condition
◉ Watch Melanoma Negative for bRAF
| Record | Firm | Date |
|---|---|---|
| Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies (NCT01794793) | RECORDATI GROUP | 2013-06-10 |
Track Melanoma Negative for bRAF automatically
Every clearance here is in the API, with alerts when new ones post.